TCL Archive DCE Board Approves New Study to Seek Causes Of Rising Breast Cancer Incidence In Young Women May 27, 1988
TCL Archive FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended July 28, 1989
TCL Archive Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested February 11, 1977
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Consensus Panel Determines Total Mastectomy Plus Node Dissection “Satisfactory Alternative” To Radical Mastectomy June 15, 1979
